CV Sciences (CVSI) Return on Invested Capital (2016 - 2026)

CV Sciences (CVSI) reported Return on Invested Capital of 0.0% for Q1 2026, up 1.0% on a YoY basis from 0.0% in Q1 2025, and down 70.71% sequentially from 0.0% in Q4 2025.

CV Sciences (CVSI) Return on Invested Capital (2016 - 2026) Analysis & Trends

CV Sciences (CVSI) has 5 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Invested Capital rose 1.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (up 1.0% YoY), and the FY2025 full-year result was 0.0%, changed N/A from the prior year.
  • Return on Invested Capital fell to 0.0% in Q1 2026, from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2025 to a low of 0.01% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.01%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 0.01%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 0.00%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.00%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.03%
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 -0.01%
Mar 31, 2025 -0.01%
Dec 31, 2018 0.16%
Sep 30, 2018 0.05%
Jun 30, 2018 0.01%
Mar 31, 2018 0.00%
Dec 31, 2017 -0.01%
Sep 30, 2017 -0.02%
Jun 30, 2017 -0.02%
Mar 31, 2017 -0.03%
Dec 31, 2016 -0.02%
Sep 30, 2016 -0.03%
Jun 30, 2016 -0.07%
Mar 31, 2016 -0.26%